Q1 2016 Holdings
Filed 2016-05-16 | 84 holdings | $82.1M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2016-05-17) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $15.4M | 245,000 | 18.7% |
| Cellectis S A(CLLS) | SPONSORED ADS | 15117K103 | $12.9M | 469,145 | 15.7% |
| Aclaris Therapeutics Inc COM(ACRS) | COM | 00461U105 | $12.3M | 647,944 | 15.0% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $12.1M | 569,130 | 14.7% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $11.5M | 1,481,075 | 14.0% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $8.2M | 450,000 | 10.0% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $4.8M | 371,023 | 5.8% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $3.1M | 1,080,000 | 3.7% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $1.1M | 61,500 | 1.4% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $203.0K | 25,000 | 0.2% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $36.7K | 1,497,475 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $33.2K | 1,750,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $30.3K | 945,000 | 0.0% |
| Omeros Corp(OMER) | COM | 682143102 | $30.1K | 1,960,000 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $27.5K | 2,000,000 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $27.3K | 485,386 | 0.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $23.9K | 700,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $23.9K | 603,900 | 0.0% |
| Eagle Pharmaceuticals Inc(EGRX) | COM | 269796108 | $20.3K | 500,000 | 0.0% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $18.8K | 975,000 | 0.0% |
| Proteostasis Therapeutics in | COM | 74373B109 | $16.6K | 1,726,599 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $14.3K | 700,000 | 0.0% |
| Quotient LTD | SHS | G73268107 | $13.4K | 1,519,100 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $13.1K | 700,000 | 0.0% |
| Tesaro Inc | COM | 881569107 | $12.8K | 291,250 | 0.0% |
| China Biologic Prods Inc | COM | 16938C106 | $12.8K | 111,500 | 0.0% |
| Vitae Pharmaceuticals Inc | COM | 92847N103 | $11.5K | 1,735,000 | 0.0% |
| Sorrento Therapeutics Inc(SRNE) | COM NEW | 83587F202 | $11.3K | 2,095,334 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $10.8K | 1,752,946 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $10.6K | 495,356 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $10.4K | 153,000 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $10.0K | 100,000 | 0.0% |
| Rockwell Medical Inc | COM | 774374102 | $8.3K | 1,105,000 | 0.0% |
| Novavax Inc | COM | 670002104 | $8.3K | 1,600,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $8.1K | 753,388 | 0.0% |
| Advaxis Inc | COM NEW | 007624208 | $7.2K | 800,000 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $6.9K | 109,500 | 0.0% |
| Celator Pharmaceuticals Inc | COM | 15089R102 | $6.8K | 620,000 | 0.0% |
| Lipocine Inc New | COM | 53630X104 | $6.8K | 666,666 | 0.0% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $6.6K | 250,000 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $6.5K | 1,559,000 | 0.0% |
| Pfenex Inc | COM | 717071104 | $6.1K | 624,900 | 0.0% |
| Forward Pharma A/S | SPONSORED ADR | 34986J105 | $5.7K | 335,068 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $5.4K | 392,079 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $5.3K | 200,000 | 0.0% |
| Recro Pharma Inc | COM | 75629F109 | $4.7K | 780,000 | 0.0% |
| Zynerba Pharmaceuticals Inc | COM | 98986X109 | $4.5K | 475,035 | 0.0% |
| Achillion Pharmaceuticals in(ACHNEUR) | COM | 00448Q201 | $3.9K | 500,000 | 0.0% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $3.5K | 170,000 | 0.0% |
| Agile Therapeutics Inc(AGRXUSD) | COM | 00847L100 | $3.5K | 557,053 | 0.0% |